Carregant...
Studies on Fragment-Based Design of Allosteric Inhibitors of Human Factor XIa
Human factor XIa (hFXIa) has emerged as an attractive target for development of new anticoagulants that promise higher level of safety. Different strategies have been adopted so far for the design of anti-hFXIa molecules including competitive and non-competitive inhibition. Of these, allosteric dysf...
Guardat en:
| Publicat a: | Bioorg Med Chem |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8109618/ https://ncbi.nlm.nih.gov/pubmed/32992249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2020.115762 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|